Oldest

psychopharmacology

·November 14, 2022·4 min read

Exposing Brain Tissue to Psilocybin Provides Insights Into Consciousness, Depression and Anxiety

Investigating how psychedelics such as psilocybin act on serotonin receptors, researchers shed new light on how the drugs affect consciousness and assist in treating a range of mental health disorders.

Featured Neuroscience Psychology

·November 15, 2022·11 min read

How Do SSRIs Like Prozac, Lexapro Really Work? Ask a Fruit Fly

Researchers shed light on how different SSRI antidepressants may work to help fight symptoms of depression in the brain.

This shows a depressed looking woman looking out a window

Featured Neuroscience Psychology

·November 15, 2022·4 min read

Potential New Lead Compounds for the Treatment of Depression and Anxiety Disorders

Study identifies potential new drugs that can help treat depression and anxiety disorders without many of the adverse effects of other medications currently under evaluation.

Featured Neuroscience Open Neuroscience Articles

·November 16, 2022·4 min read

Is Ayahuasca Safe? New Study Tallies Adverse Events

Used to help treat mental health conditions, and improve spirituality, the plant-based psychoactive ayahuasca is becoming more popular. Researchers say there is a high rate of adverse physical and psychological effects from using ayahuasca although they are not generally severe.

This shows Vyvanse (Lisdexamfetamine) 70mg capsules

Featured Neuroscience Psychology

·November 17, 2022·5 min read

ADHD Medication for Amphetamine Addiction Linked to Reduced Risk of Hospitalization and Death

Lisdexamfetamine (Vyvanse), a medication commonly used to treat ADHD, lowers the risk of hospitalization and death for those with amphetamine use disorder.

Featured Neuroscience Psychology

·November 18, 2022·5 min read

Can Pharmacotherapies Prevent Alcohol Use Disorder in People With PTSD?

Those with PTSD are almost twice as likely to develop alcohol use disorder than their peers who have not experienced trauma. Researchers report drugs that block FKBP5, such as benztropine, a drug used to control symptoms of Parkinson's disease, and the experimental compound SAFit2 reduce alcohol preference and drinking in models of PTSD.

This shows a finger touching a drawing of a brain

Featured Neuroscience

·December 2, 2022·4 min read

How Ketamine Acts as a ‘Switch’ in the Brain

Ketamine alters neural activity in the cerebral cortex, silencing normally active neurons and activating neurons that are normally inactive. The ketamine activity-induced "switch" in brain regions associated with depression may help explain its treatment effects.

Featured Neuroscience Psychology

·December 7, 2022·6 min read

Are the Youngest Children in Class Overmedicated?

Younger children in a class are more likely to be diagnosed with ADHD than their older peers. The younger children have an 80% higher risk of being prescribed medications to control ADHD.

Featured Neuroscience Open Neuroscience Articles Psychology

·December 9, 2022·4 min read

A Better Understanding of How the Most Commonly Used ADHD Medication Works

Study reveals how methylphenidate interacts with cognitive control networks and attention behaviors. Methylphenidate changes spontaneous neural activity in reward and cognitive control systems in children with ADHD. The changes result in more stable sustained attention.

Featured Neuroscience Psychology

·December 12, 2022·5 min read

The Concept of Belief Changes Related to Psychedelic Experiences

A single psychedelic experience increases beliefs about consciousness, meaning, purpose, and a range of nonphysicalist beliefs.

Featured Neuroscience Psychology

·December 16, 2022·5 min read

Inflammation May Explain Antidepressants’ Link to Preterm Birth

The common antidepressant Prozac (fluoxetine) provokes an inflammatory response in the amniotic sac. The findings may reveal the underlying factor of why women who take SSRI antidepressants are at higher risk of preterm birth.

Featured Genetics Neuroscience Psychology

·December 22, 2022·3 min read

Stem Cells May Help Identify New Schizophrenia Drugs

Researchers identified 20 drug candidates that reduce C4 immune protein secretion from astrocytes. The discovery could pave the way to treating schizophrenia and other disorders associated with C4 dysregulation in astrocytes.

1 … 24 25 26 27 28 … 32

psychopharmacology

Exposing Brain Tissue to Psilocybin Provides Insights Into Consciousness, Depression and Anxiety

How Do SSRIs Like Prozac, Lexapro Really Work? Ask a Fruit Fly

Potential New Lead Compounds for the Treatment of Depression and Anxiety Disorders

Is Ayahuasca Safe? New Study Tallies Adverse Events

ADHD Medication for Amphetamine Addiction Linked to Reduced Risk of Hospitalization and Death

Can Pharmacotherapies Prevent Alcohol Use Disorder in People With PTSD?

How Ketamine Acts as a ‘Switch’ in the Brain

Are the Youngest Children in Class Overmedicated?

A Better Understanding of How the Most Commonly Used ADHD Medication Works

The Concept of Belief Changes Related to Psychedelic Experiences

Inflammation May Explain Antidepressants’ Link to Preterm Birth

Stem Cells May Help Identify New Schizophrenia Drugs

Amygdala’s Role in Epilepsy Sudden Death

Psilocybin Microdosing Promising for Mental Health Disorders

Age-Related Changes in Spoken Word Recognition

Personality Disorders Linked to Increased Risk of Fatty Liver Disease

Subscribe